Dow (DOW) JPMorgan Industrials Conference 2026 summary

Market and industry dynamics

• Polyethylene pricing in the Americas increased in January, with global industry sales volumes reaching record highs and inventories well below the five-year average due to disciplined working capital and destocking.

• Global logistics disruptions, especially in the Middle East, have left up to 50% of polyethylene supply offline or constrained, driving urgency in price increases and operational adjustments.

• Feedstock volatility, particularly rising naphtha prices in Asia, is steepening the global cost curve and leading to operating rate reductions and force majeures for high-cost assets.

• Positive price momentum is anticipated for the second quarter, supported by seasonal demand and asset limitations in the Middle East and Asia.

• Trade and tariff volatility remains a near-term risk.

Strategic actions and transformation

• Ongoing self-help and cost-saving actions are on track, with $500 million in cost savings expected by year-end as part of a $1 billion program, and a $1 billion cost savings program to be completed in 2025.

• The 'Transform to Outperform' initiative aims to deliver at least $2 billion in near-term EBITDA improvements, with $500 million targeted for this year and $1 billion in 2026.

• Asset rationalization includes shutting down high-cost upstream and European assets, expected to deliver $200 million Op. EBITDA uplift and $60 million/year CapEx avoidance.

• Organizational changes include reducing management layers, eliminating 4,500 roles, consolidating executive roles, and workflow redesign using AI and automation.

• Commercial fundamentals are being upgraded with modern tools, and raw material sourcing strategies are being renegotiated for cost advantages.

Financial outlook and performance targets

• Near-term objectives include achieving $1 billion in quarterly EBITDA, with a longer-term goal of $1.5 billion per quarter as mid-cycle earnings.

• Free cash flow break-even is targeted at $5 billion of EBITDA, assuming 50% conversion to cash and $2.5 billion in CapEx.

• Recent legal developments resulted in a substantial cash payment from NOVA Chemicals, supporting cash flow.

• Cost reductions are tangible, with $430 million realized last year, mainly from workforce reductions, and further savings expected from supply chain and working capital improvements.

• Anticipating $500 million working capital improvements in 2026 and targeting ~$3 billion near-term Op. EBITDA uplift.